| Stacy Kennedy, | |
|
808 N 12th St, Murray, KY 42071-1666 | |
| (270) 759-1288 | |
| (270) 759-1310 |
| Full Name | Stacy Kennedy |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 808 N 12th St, Murray, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144869967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 016035 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Kennedy, 393 Elm Grove Rd, Almo, KY 42020-9147 Ph: (270) 703-4136 | Stacy Kennedy, 808 N 12th St, Murray, KY 42071-1666 Ph: (270) 759-1288 |
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
Established in 2007 and based in Toronto, ArcticDx has developed a test, Macula Risk-, the first of its kind and specifically designed to determine one's inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10% of individuals. ArcticDx will use the PBDF investment to undertake studies in support of a planned filing for Food and Drug Administration (FDA) approval for Macula Risk.
Adolescents and young adults (AYA) who have survived cancer often continue to suffer from insomnia long after treatment ends, interfering with a range of daily activities.
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
According to a new study older people who have difficulty identifying common odors may be more at risk of developing problems with thinking, learning and memory.
› Verified 7 days ago
Amilyn Nicole Arnel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 N 12th St, Murray, KY 42071 Phone: 270-759-3021 | |
Ashland Todd Price, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 N 12th St, Murray, KY 42071 Phone: 270-759-1288 Fax: 270-759-1310 | |
Martin Davenport, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 N 12th St, Murray, KY 42071 Phone: 270-753-2044 | |
Mr. Milton Dale Frizzell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1502 S 12th St, Murray, KY 42071 Phone: 270-753-3580 Fax: 270-753-8304 | |
Dr. James Joshua Owens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1205 Main St, Murray, KY 42071 Phone: 270-762-8991 | |
Dr. Chadwick Hunter Cochran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 N 12th St, Murray, KY 42071 Phone: 270-759-1288 | |
Patricia Tabers Hughes, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1296 Bazzell Cemetery Rd, Murray, KY 42071 Phone: 270-489-2041 |